ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) announced financial results for the fourth quarter and year ended December 31, 2014. For the year ended December 31, 2014, ImmunoCellular incurred a net loss of $9.4 million, or $0.16 per basic and diluted share, compared to a net loss of $8.8 million, or $0.16 per basic and diluted share, for the year ended December 31, 2013. On Tuesday shares of ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) closed at $0.54.
Energous Corporation (NASDAQ:WATT) has issued its unaudited financial results for the fourth quarter and full year ended December 31, 2014. $9.0 million in operating expenses, which consisted of $6.3 million in R&D, $1.9 million in G&A and $0.8 million in marketing expenses; Net loss (GAAP) was $9.0 million; Adjusted EBITDA (non-GAAP) loss of $8.0 million. Energous Corporation (NASDAQ:WATT) in last trading activity advanced 2.78% to close at $11.11. Company weekly performance is 17.69% while its quarterly performance stands at 34.50%. Energous Corporation (NASDAQ:WATT) is -32.42% away from its 52 week high.
On March 4, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced achievement of several clinical and regulatory milestones. These developments include top-line results from the Company’s Hepatoren Phase 2 study, submission of a supplemental New Drug Application (sNDA) with pediatric data for Caldolor and initiation of patient enrollment in the Boxaban Phase 2 clinical trial. On last trading day Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) advanced 0.59% to close at $6.87. Its volatility for the week is 5.11% while volatility for the month is 3.24%. CPIX’s sales growth for past 5 years was -1.80% and its EPS growth for past 5 years was -18.90%. Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) monthly performance is 16.84%.
Delta Air Lines Inc. (NYSE:DAL) is updating the SkyMiles program with several changes, including new one-way Award tickets beginning as low as 10,000 miles. The Atlanta-based airline (NYSE: DAL) said the new one-way Award tickets will be available through Dec. 31, for travel in select U.S., Mexican and Caribbean markets. Customers also can now fly to several Award destinations with a 21-day minimum advance purchase. On Tuesday shares of Delta Air Lines, Inc. (NYSE:DAL) closed at $43.42. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 years is recorded as 19.88%.
Research analysts at Jefferies Group decreased their target price on shares of Merck & Co. (NYSE:MRK) from $63.00 to $62.00 in a report released on Tuesday. The firm currently has a “hold” rating on the stock. Merck & Co. Inc. (NYSE:MRK) in last trading activity moved down -1.19% to close at $56.58. Company weekly performance is -3.02% while its quarterly performance stands at -7.29%. Merck & Co. Inc. (NYSE:MRK) is -11.07% away from its 52 week high.